These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 33991070)

  • 1. Pyroptosis-related long-noncoding RNA signature predicting survival and immunotherapy efficacy in patients with lung squamous cell carcinoma.
    Zhan X; Li J; Ding Y; Zhou F; Zeng R; Lei L; Zhang Y; Feng A; Qu Y; Yang Z
    Clin Exp Med; 2024 Jul; 24(1):145. PubMed ID: 38960987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic Significance of Glycolysis-Related Genes in Lung Squamous Cell Carcinoma.
    Kadasah SF
    Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38256214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification and prognostic value of a glycolysis-related gene signature in patients with bladder cancer.
    Wu Z; Wen Z; Li Z; Yu M; Ye G
    Medicine (Baltimore); 2021 Jan; 100(3):e23836. PubMed ID: 33545950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epithelial-mesenchymal transition-related gene signature for prognosis of lung squamous cell carcinoma.
    Yu H; Dai C; Li J; Zhang X
    Medicine (Baltimore); 2023 Jul; 102(28):e34271. PubMed ID: 37443495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The necroptosis signature and molecular mechanism of lung squamous cell carcinoma.
    Song GQ; Wu HM; Ji KJ; He TL; Duan YM; Zhang JW; Hu GQ
    Aging (Albany NY); 2023 Nov; 15(22):12907-12926. PubMed ID: 37976123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of SLC2A1 as a predictive biomarker for survival and response to immunotherapy in lung squamous cell carcinoma.
    Hao B; Dong H; Xiong R; Song C; Xu C; Li N; Geng Q
    Comput Biol Med; 2024 Mar; 171():108183. PubMed ID: 38422959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA-PK-Mediated Cytoplasmic DNA Sensing Stimulates Glycolysis to Promote Lung Squamous Cell Carcinoma Malignancy and Chemoresistance.
    Wang H; Zhang Y; Tian Y; Yang W; Wang Y; Hou H; Pan H; Pei S; Zhu H; Gu Z; Zhang Y; Dai D; Chen W; Zheng M; Luo Q; Xiao Y; Huang J
    Cancer Res; 2024 Mar; 84(5):688-702. PubMed ID: 38199791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A four-gene-based methylation signature associated with lymph node metastasis predicts overall survival in lung squamous cell carcinoma.
    Deng Y; Liu L; Xiao X; Zhao Y
    Genes Genet Syst; 2023 Nov; 98(5):209-219. PubMed ID: 37839873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIF1A-dependent overexpression of MTFP1 promotes lung squamous cell carcinoma development by activating the glycolysis pathway.
    Ji J; Wang Y; Jing A; Ma L; Yang J; Ren D; Lv J; Lv M; Xu M; Yuan Q; Ma X; Qian Q; Wang W; Geng T; Ding Y; Qin J; Liu Y; Zhou J; Zuo L; Ma S; Wang X; Liu B
    Heliyon; 2024 Apr; 10(7):e28440. PubMed ID: 38689964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NPLOC4 is a potential target and a poor prognostic signature in lung squamous cell carcinoma.
    Wang N; Zhu D; Liu Y; Wu J; Wang M; Jin S; Fu F; Li B; Ji H; Du C; Zheng Z
    Sci Rep; 2023 Nov; 13(1):20430. PubMed ID: 37993584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Somatic genome alterations in relation to age in lung squamous cell carcinoma.
    Meucci S; Keilholz U; Heim D; Klauschen F; Cacciatore S
    Oncotarget; 2018 Aug; 9(63):32161-32172. PubMed ID: 30181806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microbiota modulate lung squamous cell carcinoma lymph node metastasis through microbiota-geneset correlation network.
    Liang P; Deng H; Zhao Y; Chen Y; Zhang J; He J; Liang W
    Transl Lung Cancer Res; 2023 Nov; 12(11):2245-2259. PubMed ID: 38090530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of Camrelizumab Combined with First-Line Chemotherapy on Serum SCC, VEGF Levels, and Adverse Reactions in Patients with Advanced Squamous Cell Carcinoma of the Lung.
    Wang Z; Xuan Y; Shao Y; Zou Q; Cui H; Jin X
    Comput Intell Neurosci; 2022; 2022():3137370. PubMed ID: 36438688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The hexokinase "HKDC1" interaction with the mitochondria is essential for liver cancer progression.
    Khan MW; Terry AR; Priyadarshini M; Ilievski V; Farooq Z; Guzman G; Cordoba-Chacon J; Ben-Sahra I; Wicksteed B; Layden BT
    Cell Death Dis; 2022 Jul; 13(7):660. PubMed ID: 35902556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and Validation of a 7-Gene Inflammatory Signature Forecasts Prognosis and Diverse Immune Landscape in Lung Adenocarcinoma.
    Nai A; Ma F; He Z; Zeng S; Bashir S; Song J; Xu M
    Front Mol Biosci; 2022; 9():822739. PubMed ID: 35372503
    [No Abstract]   [Full Text] [Related]  

  • 16. Identification of a glycolysis-related gene signature associated with clinical outcome for patients with lung squamous cell carcinoma.
    Xu Z; Zhang S; Nian F; Xu S
    Cancer Med; 2021 Jun; 10(12):4017-4029. PubMed ID: 33991070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A glycolysis-based three-gene signature predicts survival in patients with lung squamous cell carcinoma.
    Huang G; Zhang J; Gong L; Huang Y; Liu D
    BMC Cancer; 2021 May; 21(1):626. PubMed ID: 34044809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of a seven-miRNA signature as prognostic biomarker for lung squamous cell carcinoma.
    Gao X; Wu Y; Yu W; Li H
    Oncotarget; 2016 Dec; 7(49):81670-81679. PubMed ID: 27835574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification and validation of an individualized prognostic signature of lung squamous cell carcinoma based on ferroptosis-related genes.
    Diao X; Guo C; Liu L; Wang G; Li S
    Thorac Cancer; 2021 Dec; 12(23):3236-3247. PubMed ID: 34672420
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.